Follow
Marc S. Sabatine
Marc S. Sabatine
TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School
Verified email at partners.org
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
250282017
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
165492014
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on …
RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin III, ...
Circulation 129 (23), e521-e643, 2014
9376*2014
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
82352020
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
DC Goff Jr, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, ...
Circulation 129 (25_suppl_2), S49-S73, 2014
70032014
2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association …
EA Amsterdam, NK Wenger, RG Brindis, DE Casey, TG Ganiats, ...
Journal of the American College of Cardiology 64 (24), e139-e228, 2014
6252*2014
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
57652019
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
57502019
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
56122017
Cytochrome p-450 polymorphisms and response to clopidogrel
JL Mega, SL Close, SD Wiviott, L Shen, RD Hockett, JT Brandt, JR Walker, ...
New England journal of medicine 360 (4), 354-362, 2009
31212009
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
29192005
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American …
GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn, LA Fleisher, ...
Circulation 134 (10), e123-e155, 2016
28522016
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome …
TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ...
The Lancet 393 (10166), 31-39, 2019
26132019
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
21522015
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA De Lemos, DA Morrow, JH Bentley, T Omland, MS Sabatine, ...
New England Journal of Medicine 345 (14), 1014-1021, 2001
21162001
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
18782011
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
16742015
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ...
Jama 304 (16), 1821-1830, 2010
13962010
Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis
MG Silverman, BA Ference, K Im, SD Wiviott, RP Giugliano, SM Grundy, ...
Jama 316 (12), 1289-1297, 2016
13562016
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in …
MS Sabatine, DA Morrow, KA Jablonski, MM Rice, JW Warnica, ...
Circulation 115 (12), 1528-1536, 2007
1147*2007
The system can't perform the operation now. Try again later.
Articles 1–20